Short-term Insomnia Clinical Trial
Official title:
"Chou's Tiaoshen" Acupoints for Short-term Insomnia: A Multicenter, Randomized, Controlled Clinical Study.
The goal of this clinical trial is to learn about the curative effect of "Chou's Tiaoshen" acupoints in short-term insomnia and the explore the possible mechanism of the action. The main questions it aims to answer are: - Whether the curative effect of caupuncturing"Chou's Tiaoshen" acupoints in the treatment of short-term insomnia is not inferior to that of Esazolam. - What is the possible mechanism of acupuncture "Chou's Tiaoshen"acupoints for short-term insomnia. Participants with short-term insomnia who met the criteria will be randomly assigned to "Chou's Tiaoshen"acupoints group and Esazolam group. Polysomnography, heart rate variability, cortisol and related scales will be measured before and after treatment to detect the changes in symptoms and signs before and after treatment.
Status | Not yet recruiting |
Enrollment | 96 |
Est. completion date | May 1, 2025 |
Est. primary completion date | March 1, 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 70 Years |
Eligibility | Inclusion Criteria: 1. Meet diagnostic criteria for short-term insomnia according to the Diagnostic and Statistical Manual of Mental Disorders Text Revision, 5th ed (DSM-V) and Chinese Adult Insomnia Diagnosis and Treatment Guide 2017,a predominant complaint of dissatisfaction with sleep quantity or quality, associated with one (or more) of the following symptoms: 1)Difficulty initiating sleep. 2). Difficulty maintaining sleep, characterized by frequent awakenings or problems returning to sleep after awakenings. 3)Early-morning awakening with inability to return to sleep. 4)The sleep disturbance causes clinically significant distress or impairment in social, occupational, educational, academic, behavioral, or other important areas of functioning. The sleep difficulty occurs at least 3 nights per week. The duration of the sleep difficulty is 1 week to 3 months. 2. Experienced insomnia between 1 weeks and 3 months before the start of project. 3. Age: patients between 18 and 70 years old. 4. Patients who agreed to participant in this trial and assigned the informed consent. Exclusion Criteria: 1. People with other DSM-IV Axis I, Axis II mental disorders or substance abuse/dependence; 2. Patients with serious primary diseases such as cardiovascular and cerebrovascular diseases, hypertension, digestive system, hematopoietic system, liver, kidney, or severe anxiety and depression; 3. Caused by alcohol or drugs; 4. Pregnant or lactating women; 5. Easy to combine infection and bleeding; 6.1 Patients who have used psychotropic drugs, such as antidepressants, mania drugs or other drugs used to treat psychosis, in the last month, and patients who have taken sleeping pills in the last 1 month; 7. Those who cannot cooperate with treatment. |
Country | Name | City | State |
---|---|---|---|
China | Beijing Hospital of Traditional Chinese Medicine | Beijing | Beijing |
Lead Sponsor | Collaborator |
---|---|
Beijing Hospital of Traditional Chinese Medicine |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Pittsburgh Sleep Quality Index | The Pittsburgh Sleep Quality Index (PSQI) is a self-rated questionnaire which assesses sleep quality and disturbances. Eighteen individual items generate seven "component" scores: subjective sleep quality (SQ), sleep-onset latency (SOL), total sleep time (TST), habitual sleep efficiency (SE), sleep disturbances ( Dyssomnia), use of sleeping medication, and daytime dysfunction (DD).The cumulative component score is the PSQI total score ranging from 0 to 21, higher scores indicates worse sleep quality. | PSQI will be recorded 3 times, before treatment, and at the 14th day , 28th day after treatment. | |
Secondary | Polysomnography | Polysomnography (PSG) is a classic instrument for detecting sleep conditions.The following data can be obtained by PSG monitoring: total sleep time, sleep latency, The percentage of time spent in each sleep stage. PSG is of great value for the degree and differential diagnosis of insomnia. | PSG will be recorded in 10 randomly selected patients in each group before treatment and 14 days after treatment. | |
Secondary | Heart Rate Variability (HRV) | The degree and regularity of heart rate changes can be reflected by measuring the variability of continuous normal R-R interphase changes by dynamic elctrocardiogram, so as to judge its impact on cardiovascular activities, which can reflect the activity of autonomic nervous system and quantitatively evaluate the balance of sympathetic and vagal nerve tension. | HRV will be recorded 3 times, before treatment, at the 14th day and 28th day after treatment. | |
Secondary | Concentration of serum cortisol | Serum cortisol is elevated during stress, which can reflect excessive arousal, and if the brain is constantly under high stress, may lead to long-term elevated cortisol levels. | Serum cortisol will be recorded 2 times, before treatment, and at the 14th day , 28th day after treatment, and the measurement time was fixed at 8 am each time. | |
Secondary | Fatigue Scale | The fatigue scale(FS) consists of 14 items, each of which is a fatigue-related question, reflecting both physical fatigue and mental fatigue. The highest total score is 14 points, the lowest is 0 points, and the higher the score is, the more serious the fatigue is. | FS will be recorded 3 times, before treatment, and at the 14th day , 28th day after treatment. | |
Secondary | Ford Insomnia Response to Stress Test Chinese version,FIRST | FIRST is a self-reporting tool including nine items designed to assess sleep response, The minimum total score is 9 and the maximum is 36. Higher scores on the FIRST indicate a more highly reactive sleep system. | FIRST will be recorded 3 times, before treatment, and at the 14th day , 28th day after treatment. | |
Secondary | Traditional Chinese medicine symptom scoring Scale | The TCM symptom scoring scale consists of five items with a minimum score of 0 and a maximum score of 30, reflecting the five core symptoms of insomnia, with higher scores indicating more severe symptoms. | TCM symptom score will be recorded 3 times, before treatment, and at the 14th day , 28th day after treatment. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02671760 -
Pilot Study of a Combination Drug Product for Treatment of Short-term Insomnia
|
Phase 2 |